Association of bronchial hyprerresponisiveness and lung function with C-reactive protein (CRP): a population based study

Kony, S.; Zureik, M.; Driss, F.; Neukirch, C.; Leynaert, B.; Neukirch, F.
October 2004
Thorax;Oct2004, Vol. 59 Issue 10, p892
Academic Journal
Background: C-reactive protein (CRP), a marker of systemic inflammation, is a powerful predictor of adverse cardiovascular events. Respiratory impairment is also associated with cardiovascular risk. Although some studies have found an inverse relationship between lung function and markers of systemic inflammation, only one study has reported a relationship between lung function and CRP levels. In contrast, little is known about the relationship between bronchial hyperresponsiveness (BHR) and systemic inflammation. The association between lung function and CRP and between BHR and CRP has been investigated. Methods: As part of the European Community Respiratory Health Survey follow up study serum CRP levels, forced expiratory volume in 1 second (FEV1), and BHR to methacholine (⩾20% decrease in FEY1 to <4 mg methacholine) were measured in 259 adults aged 28-56 years free of cardiovascular disease or respiratory infection. Results: Mean (SD) FEV1 (adjusted for age, sex, height, and smoking status) was lower in subjects with a high CRP level (high tertile) (3.29 .(0.44) I/s v 3.50 (0.44) l/s; p<0.01) and BHR was more frequent (41.9% v 24.9%; p=0.005) than in subjects with lower CRP levels (low+middle tertiles). Similar results were obtained when the potential confounding factors were taken into account. Similar patterns of results were found in non-smokers and in non-asthmatic subjects. Conclusions: Increased CRP levels are strongly and independently associated with respiratory impairment and more frequent BHR. These results suggest that both respiratory impairment and BHR are associated with a systemic inflammatory process.


Related Articles

  • Markers of experimental acute inflammation in the Wistar Han rat with particular reference to haptoglobin and C-reactive protein. Giffen, P. S.; Turton, J.; Andrews, C. M.; Barrett, P.; Clarke, C. J.; Fung, K.-W.; Munday, M. R.; Roman, I. F.; Smyth, R.; Walshe, K.; York, M. J. // Archives of Toxicology;Jul2003, Vol. 77 Issue 7, p392 

    C-reactive protein (CRP), haptoglobin (Hp) and fibrinogen (Fbgn) are acute phase reactants (APRs), the blood levels of which increase during acute inflammation. However, although the levels of these APRs are used to monitor inflammation in man, their usefulness and sensitivity as markers of...

  • Chemical knockout of C-reactive protein in cardiovascular disease. Heinecke, Jay W. // Nature Chemical Biology;Jun2006, Vol. 2 Issue 6, p300 

    The article talks about the human C-reactive protein (CRP) which has been implicated in inflammatory responses associated with heart attacks and strokes. Humans and mammals go through a series of biochemical and physiological changes during infection, tissue damage or acute inflammation. This is...

  • Pre-eclampsia linked to higher lifetime CVD risk.  // GP: General Practitioner;3/31/2006, p4 

    The article focuses on a study conducted in the U.S., according to which women who have an eclamptic pregnancy are still at increased risk of cardiovascular disease (CVD) up to 30 years later. Levels of the inflammatory marker C-reactive protein, were found to be twice as high in post-menopausal...

  • The Level of hs-CRP in Coronary Artery Ectasia and Its Response to Statin and Angiotensin-Converting Enzyme Inhibitor Treatment. Ozbay, Yilmaz; Akbulut, Mehmet; Balin, Mehmet; Kayancicek, Hidayet; Baydas, Adil; Korkmaz, Hasan // Mediators of Inflammation;2/1/2007, Vol. 2007 Issue 1, Special section p1 

    Background/Aim. Coronary artery ectasia (CAE) was thought of as a variant of atherosclerosis. C-reactive protein (CRP) which is among the most sensitive markers of systemic inflammation, and elevation of systemic and local levels of this inflammatory marker which has been associated with an...

  • Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Koenig; Danesh, John; Whincup, Peter; Walker, Mary; Lennon, Lucy; Thomson, Andrew; Appleby, Paul; Gallimore, J Ruth; Pepys, Mark B // BMJ: British Medical Journal (International Edition);07/22/2000, Vol. 321 Issue 7255, p199 

    AbstractObjective: To assess associations between baseline values of four different circulating markers of inflammation and future risk of coronary heart disease, potential triggers of systemic inflammation (such as persistent infection), and other markers of inflammation.Design: Nested...

  • Effects of Antisense Oligonucleotides against C-Reactive Protein on the Development of Atherosclerosis in WHHL Rabbits. Qi Yu; Zhengcao Liu; Ahmed Bilal Waqar; Bo Ning; Xianghong Yang; Masashi Shiomi; Graham, Mark J.; Crooke, Rosanne M.; Enqi Liu; Sijun Dong; Jianglin Fan // Mediators of Inflammation;2014, Vol. 2014, p1 

    Increased plasma levels of C-reactive protein (CRP) are closely associated with cardiovascular diseases, but whether CRP is directly involved in the pathogenesis of atherosclerosis is still under debate. Many controversial and contradictory results using transgenic mice and rabbits have been...

  • The Utility of Serum Tryptase as a Marker in Chronic Spontaneous Urticaria. Siles, Roxana; Meng Xu; Hsieh, Fred H. // Acta Dermato-Venereologica;2013, Vol. 93 Issue 3, p354 

    The article presents a study which examined patients with chronic spontaneous urticaria (CsU) and elevated total serum tryptase (tST). The researchers reviewed the data on patients with CsU who underwent tST assessment using fluorescent enzyme immunoassay from 2004-2011. The complete blood...

  • Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report. Kjelgaard-Hansen, Mads; Jensen, Asger Lundorff; Houser, Geoffrey A.; Jessen, Lisbeth Rem; Kristensen, Annemarie T. // Acta Veterinaria Scandinavica;2006, Vol. 47, p9 

    Background: Monitoring systemic inflammatory activity during steroid therapy of canine immune-mediated polyarthritis (IMPA) is difficult and mainly relies on clinical signs. Case presentation: Canine serum C-reactive protein (CRP) was measured serially and blinded during a 27-week follow-up...

  • CRP level not helpful in predicting breast cancer.  // Contemporary OB/GYN;Oct2007, Vol. 52 Issue 10, p25 

    This article discusses findings of a study, which revealed that baseline plasma C-reactive protein (CRP) is not associated with an increased risk for the disease in otherwise healthy women. CRP is a marker of systemic inflammation. The study founded that almost 900 women developed invasive...


Read the Article


Sign out of this library

Other Topics